Mai Okada
Overview
Explore the profile of Mai Okada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sakata K, Hashimoto A, Kambe T, Sato J, Ohga N, Yamazaki Y, et al.
J Med Case Rep
. 2024 Apr;
18(1):198.
PMID: 38570871
Background: The activity level of alkaline phosphatase, a zinc-requiring enzyme in the serum, is used to indicate zinc nutritional status; however, it does not correlate with serum zinc levels or...
2.
Takeji S, Okada M, Hayashi S, Kanamaru K, Uno Y, Imaishi H, et al.
Biopharm Drug Dispos
. 2023 Oct;
44(6):420-430.
PMID: 37815926
CYP2C19 is a member of the human microsomal cytochrome P450 (CYP). Significant variation in CYP2C19 levels and activity can be attributed to polymorphisms in this gene. Wildtype CYP2C19 and 13...
3.
Suzuki R, Yao T, Okada M, Nagai H, Khurchabilig A, Kobayashi J, et al.
Theriogenology
. 2023 Feb;
200:96-105.
PMID: 36805250
Direct cleavage, a type of abnormal cleavage in which one zygote divides into three or more blastomeres, has been reported in mammals. The incidence of direct cleavage increases in zygotes...
4.
Mashima Y, Koizumi T, Minegishi S, Miyakoshi M, Okada M, Ogyu K, et al.
Int J Soc Psychiatry
. 2022 Jun;
68(5):969-980.
PMID: 35652327
Background: The coronavirus disease 2019 (COVID-19) pandemic has resulted in a total upending of our daily lives. While anxiety and depression were frequently reported among the general population, the pandemic's...
5.
Nagai H, Okada M, Nagai Y, Sakuraba Y, Okae H, Suzuki R, et al.
Biochem Biophys Res Commun
. 2021 May;
562:76-82.
PMID: 34044324
Chromosome instability leading to aneuploidy during early cleavage is well known in humans and cattle. Partial compaction (PC), which occurs only in some blastomeres, is suggested as a self-correction mechanism...
6.
Suzuki R, Okada M, Nagai H, Kobayashi J, Sugimura S
Theriogenology
. 2021 Mar;
166:55-63.
PMID: 33689928
The morphokinetics of pronuclei (PN) are considered crucial factors affecting embryogenesis in mammals. Whereas, since bovine zygotes contain a large number of cytosolic lipid droplets, detailed observation of PN has...
7.
Asano R, Hosokawa K, Taki S, Konno S, Shimomura I, Ogata H, et al.
Sci Rep
. 2020 Mar;
10(1):4913.
PMID: 32188928
Designing non-natural antibody formats is a practical method for developing highly functional next-generation antibody drugs, particularly for improving the therapeutic efficacy of cancer treatments. One approach is constructing bispecific antibodies...
8.
Yoshida K, Okada M, Nagasaka R, Sasaki H, Okada M, Kanie K, et al.
J Biosci Bioeng
. 2019 Feb;
128(2):209-217.
PMID: 30738731
Increasing the yield and maintaining a high quality of induced pluripotent stem cells (iPSCs) is necessary for manufacturing iPSCs at the industrial scale. However, because iPSCs are delicate, it is...
9.
Imai Y, Yoshida K, Matsumoto M, Okada M, Kanie K, Shimizu K, et al.
Regen Ther
. 2018 Dec;
9:15-23.
PMID: 30525071
Introduction: Advancing industrial-scale manufacture of cells as therapeutic products is an example of the wide applications of regenerative medicine. However, one bottleneck in establishing stable and efficient cell manufacture is...
10.
Nagasaka R, Matsumoto M, Okada M, Sasaki H, Kanie K, Kii H, et al.
Regen Ther
. 2018 Oct;
6:41-51.
PMID: 30271838
From the recent advances, there are growing expectations toward the mass production of induced pluripotent stem cells (iPSCs) for varieties of applications. For such type of industrial cell manufacturing, the...